vorinostat has been researched along with Endometriosis in 2 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Endometriosis: A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Imesch, P | 1 |
Samartzis, EP | 1 |
Dedes, KJ | 1 |
Fink, D | 1 |
Fedier, A | 1 |
Kawano, Y | 1 |
Nasu, K | 1 |
Li, H | 1 |
Tsuno, A | 1 |
Abe, W | 1 |
Takai, N | 1 |
Narahara, H | 1 |
2 other studies available for vorinostat and Endometriosis
Article | Year |
---|---|
Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells.
Topics: Benzodioxoles; Cell Line, Transformed; Cell Proliferation; Depsipeptides; Down-Regulation; Drug Eval | 2013 |
Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target.
Topics: Acetylation; Adult; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Checkpoint Kinase 2; Cycl | 2011 |